phio pharmaceuticals - Robuta Search

https://finviz.com/quote?t=PHIO&ta=1&p=d PHIO - Phio Pharmaceuticals Corp Stock Price and Quote PHIO - Phio Pharmaceuticals Corp - Stock screener for investors and traders, financial visualizations. phio pharmaceuticals stock price corp quote https://finviz.com/quote?t=PHIO&ta=1&p=d&ty=fc PHIO - Phio Pharmaceuticals Corp Forecast, Target Price PHIO - Phio Pharmaceuticals Corp - Stock screener for investors and traders, financial visualizations. phio pharmaceuticals corp forecast target price https://www.home.saxo/cs-cz/markets/stocks/phio-xnas Phio Pharmaceuticals Corp. akcie | Saxo Bank Phio Pharmaceuticals Corp is a clinical-stage biopharmaceutical company whose proprietary INTASYL small-interfering RNA gene silencing technology is designed... phio pharmaceuticals corp akcie saxo bank https://www.prnewswire.com/news-releases/phio-pharmaceuticals-announces-research-collaboration-with-carisma-therapeutics-to-evaluate-its-self-delivering-rnai-technology-to-enhance-macrophage-based-adoptive-cell-therapy-300913536.html Phio Pharmaceuticals Announces Research Collaboration with Carisma Therapeutics to Evaluate its... /PRNewswire/ -- Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a biotechnology company developing the next generation of immuno-oncology therapeutics based on... phio pharmaceuticals research collaboration announces https://finviz.com/news/308970/whats-going-on-with-tiny-cancer-biotech-phio-pharmaceuticals-on-thursday What's Going On With Tiny Cancer Biotech Phio Pharmaceuticals On Thursday? Stock screener for investors and traders, financial visualizations. what s going on phio pharmaceuticals https://www.newsfilecorp.com/release/286314 Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Live Virtual... phio pharmaceuticals in the financial communications announces participation https://www.biospace.com/phio-pharmaceuticals-announces-closing-of-4-million-concurrent-registered-direct-offering-and-private-placement-priced-at-the-market-under-nasdaq-rules Phio Pharmaceuticals Announces Closing of $4 Million Concurrent Registered Direct Offering and... Jun 5, 2023 - Phio Pharmaceuticals Corp. announced the closing of its previously announced registered direct offering of 233,646 shares of common stock, at a purchase price... phio pharmaceuticals of 4 https://www.prnewswire.com/news-releases/phio-pharmaceuticals-announces-upcoming-data-presentation-at-the-esmo-virtual-congress-2021-301365371.html Phio Pharmaceuticals Announces Upcoming Data Presentation at the ESMO Virtual Congress 2021 /PRNewswire/ -- Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a biotechnology company developing the next generation of immuno-oncology therapeutics based on... phio pharmaceuticals data presentation https://www.benzinga.com/quote/PHIO/short-interest Phio Pharmaceuticals Stock Short Interest Report | NASDAQ:PHIO | Benzinga Short interest for Phio Pharmaceuticals gives investors a sense of the degree to which investors are betting on the decline of Phio Pharmaceuticals's stock.... phio pharmaceuticals short interest stock report nasdaq https://www.newsfilecorp.com/release/291688/Phio-Pharmaceuticals-Announces-Presentation-at-Centri-Capital-Conference-on-April-14-2026 Phio Pharmaceuticals Announces Presentation at Centri Capital Conference on April 14, 2026 King of Prussia, Pennsylvania--(Newsfile Corp. - April 9, 2026) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical... centri capital conference phio pharmaceuticals https://www.financialcontent.com/quote/NQ:PHIO/about The History Of Phio Pharmaceuticals Corp. - Common Stock (Nasdaq:PHIO) | FinancialContent Phio Pharmaceuticals Corp., traded under the ticker PHIO on the Nasdaq exchange, is an example of a clinical-stage biotechnology company whose story weaves... the history of phio pharmaceuticals common stock corp nasdaq https://finviz.com/quote?t=PHIO&ta=1&p=d&ty=oc PHIO - Phio Pharmaceuticals Corp Options PHIO - Phio Pharmaceuticals Corp - Stock screener for investors and traders, financial visualizations. phio pharmaceuticals corp options https://www.macrotrends.net/stocks/charts/PHIO/phio-pharmaceuticals/total-share-holder-equity Phio Pharmaceuticals Share Holder Equity 2012-2025 | PHIO | MacroTrends Phio Pharmaceuticals share holder equity from 2012 to 2025. Share holder equity can be defined as the sum of preferred and common equity items phio pharmaceuticals share holder equity 2012 2025 https://www.biospace.com/press-releases/phio-pharmaceuticals-reports-second-quarter-2024-financial-results-and-provides-business-update Phio Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update -... 2024 financial results phio pharmaceuticals second quarter https://www.newsfilecorp.com/release/291688 Phio Pharmaceuticals Announces Presentation at Centri Capital Conference on April 14, 2026 King of Prussia, Pennsylvania--(Newsfile Corp. - April 9, 2026) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical... centri capital conference phio pharmaceuticals https://www.benzinga.com/quote/PHIO/analyst-ratings Phio Pharmaceuticals Analyst Ratings and Price Targets | NASDAQ:PHIO | Benzinga Explore Phio Pharmaceuticals analyst ratings and price targets (NASDAQ:PHIO) on Benzinga. Stay updated on expert opinions and forecasts for PHIO stock. phio pharmaceuticals analyst ratings price targets nasdaq benzinga https://www.newsfilecorp.com/release/256738/Phio-Pharmaceuticals-Announces-Positive-Safety-Monitoring-Committee-Recommendation-to-Advance-INTASYL-PH762-Skin-Cancer-Clinical-Trial-to-Fifth-Dose-Escalation-Cohort Phio Pharmaceuticals Announces Positive Safety Monitoring Committee Recommendation to Advance... -Phio's lead clinical siRNA compound PH-762 demonstrates supportive safety profile in fourth cohort, permitting dose escalation in expected final... phio pharmaceuticals safety monitoring announces positive committee https://www.home.saxo/nb-no/markets/stocks/phio-xnas Phio Pharmaceuticals Corp. aksje | Saxo Bank Phio Pharmaceuticals Corp is a clinical-stage biopharmaceutical company whose proprietary INTASYL small-interfering RNA gene silencing technology is designed... phio pharmaceuticals corp aksje saxo bank https://www.newsfilecorp.com/release/250330/Phio-Pharmaceuticals-Announces-Participation-in-the-Renmark-Financial-Communications-Virtual-NonDeal-Roadshow-Series Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Virtual... Marlborough, Massachusetts--(Newsfile Corp. - May 1, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company... phio pharmaceuticals in the financial communications announces participation https://www.home.saxo/markets/stocks/phio-xnas Phio Pharmaceuticals Corp. stock | Saxo Phio Pharmaceuticals Corp is a clinical-stage biopharmaceutical company whose proprietary INTASYL small-interfering RNA gene silencing technology is designed... phio pharmaceuticals corp stock saxo https://www.benzinga.com/quote/PHIO/news Latest Phio Pharmaceuticals Stock News | NASDAQ:PHIO | Benzinga Get the latest news on Phio Pharmaceuticals stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on PHIO performance phio pharmaceuticals stock news latest nasdaq benzinga https://www.newsfilecorp.com/company/10407/ Phio Pharmaceuticals Corp. | TMX Newsfile Phio Pharmaceuticals Corp. at TMX Newsfile phio pharmaceuticals corp tmx newsfile https://phiopharma.com/ Home - Phio Pharmaceuticals Dec 16, 2025 - Innovative Pathways Toward a Cancer-Free Future phio pharmaceuticals https://www.newsfilecorp.com/release/292112/Phio-Pharmaceuticals-Announces-Nobel-Prize-Winning-Science-Takes-on-Skin-Cancer-in-a-Fireside-Chat-with-Force-Family-Office-on-Wednesday-April-15-2026 Phio Pharmaceuticals Announces "Nobel Prize Winning Science Takes on Skin Cancer" in a Fireside... Phio invites investors, advisors and analysts with an interest in the life sciences sector to attend this virtual eventR.... https://www.newsfilecorp.com/release/273014/Phio-Pharmaceuticals-Announces-Exercise-of-Warrants-for-Approximately-13.4-Million-Gross-Proceeds Phio Pharmaceuticals Announces Exercise of Warrants for Approximately $13.4 Million Gross Proceeds King of Prussia, Pennsylvania--(Newsfile Corp. - November 3, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage siRNA biopharmaceutical... https://www.biospace.com/phio-pharmaceuticals-announces-exercise-of-warrants-for-3-1-million-gross-proceeds Phio Pharmaceuticals Announces Exercise of Warrants for $3.1 Million Gross Proceeds - BioSpace